Value of fluorodeoxyglucose positron emission tomography in women with breast cancer

British Journal of Surgery

Volumn 92, Issue 11, 2005, Pages 1363-1367

  Landheer, M L E A ^a   Steffens, M G ^a   Klinkenbijl, J H G ^a   Westenberg, A H ^b   Oyen, W J G ^c  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b Institute for Radiation Oncology Arnhem   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 27544506959     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.5046     Document Type: Article

References (27)

1. Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001; 2: 157-164.
2. Hustinx R, Benard F, Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med 2002; 32: 35-46.
3. Jerusalem G, Hustinx R, Beguin Y, Fillet G. PET scan imaging in oncology. Eur J Cancer 2003; 39: 1525-1534.
4. Dose J, Bleckmann C, Bachmann S, Bohuslavizki KH, Berger J, Jenicke L et al. Comparison of fluorodeoxyglucose positron emission tomography and 'conventional diagnostic procedures' for the detection of distant metastases in breast cancer patients. Nucl Med Commun 2002; 23: 857-864.
5. 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography in staging of locally advanced breast cancer. J Clin Oncol 2004; 22: 1253-1259.
6. Rostom AY, Powe J, Kandil A, Ezzat A, Bakheet S, el-Khwsky F et al. Positron emission tomography in breast cancer: a clinicopathological correlation of results. Er J Radiol 1999; 72: 1064-1068.
7. Siggelkow W, Zimny M, Faridi A, Petzold K, Buell U, Rath W. The value of positron emission tomography in the follow-up for breast cancer. Anticancer Res 2003; 23: 1859-1867.
8. 18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer. J Cancer Res Clin Oncol 2003; 129: 147-153.
9. Lin WY, Tsai SC, Cheng KY, Yen RF, Kao CH. Fluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer - Taiwanese experiences. Cancer Invest 2002; 20: 725-729.
10. Kim TS, Moon WK, Lee DS, Chung JK, Lee MC, Youn YK et al. Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer. World J Surg 2001; 25: 829-834.
11. Schirrmeister H, Kuhn T, Guhlmann A, Santjohanser C, Horster T, Nussle K et al. Fluorine-18 2deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 2001; 28: 351-358.
12. Moon DH, Maddahi J, Silverman DH, Glaspy JA, Phelps ME, Hoh CK. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 1998; 39: 431-435.
13. Bombardieri E, Crippa F. PET imaging in breast cancer. Q J Nucl Med 2001; 45: 245-256.
14. 18-Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 2001; 19: 3516-3523.
15. Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK et al. Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics 2002; 22: 5-17.
16. Pastorino U, Veronesi G, Landoni C, Leon M, Picchio M, Solli PG et al. Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis. J Thorac Cardiovasc Surg 2003; 126: 1906-1910.
17. 18fluoro-deoxyghicose positron emission tomography in the staging of recurrent breast carcinoma. Anticancer Res 1997; 17: 1687-1692.
18. Reynolds HY. Diagnostic and management strategies for diffuse interstitial lung disease. Chest 1998; 113: 192-202.
19. Schneider C, Fehr MK, Steiner RA, Hagen D, Haller U, Fink D. Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet 2003; 269: 9-12.
20. Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P et al. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol 2003; 38: 250-256.
21. Ohta M, Tokuda Y, Suzuki Y, Kubota M, Makuuchi H, Tajima T et al. Whole body PET for the evaluation of bone metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun 2001; 22: 875-879.
22. Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by FDG-PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998; 16: 3375-3379.
23. 18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol 1993; 51: 175-181.
24. Zangheri B, Messa C, Picchio M, Gianolli L, Landoni C, Fazio F. PET/CT and breast cancer. Eur J Nucl Med Mol Imaging 2004; 31(Suppl 1): S135-S142.
25. Suarez M, Perez-Castejon MJ, Jimenez A, Domper M, Ruiz G, Montz R et al. Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers. Q J Nucl Med 2002; 46: 113-121.
26. 18F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report. Jpn J Clin Oncol 2002; 32: 244-247.
27. Pecking AP, Mechelany-Corone C, Bertrand-Kermorgant F, Alberini JL, Floiras JL, Goupil A et al. Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography. Clin Breast Cancer 2001; 2: 229-234.